Inhaled Melatonin (100 μg)

DRUG2 trials

Sponsors

Woolcock Institute of Medical Research

Conditions

Insomnia

Early Phase 1

A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study

RecruitingNCT06801379

Woolcock Institute of Medical ResearchInsomnia

Start: 2025-07-01End: 2026-05-01Target: 5Updated: 2025-07-18

A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Efficacy Study

RecruitingNCT06802913

Woolcock Institute of Medical ResearchInsomnia

Start: 2025-07-01End: 2026-05-31Target: 10Updated: 2025-07-18